Qureight

Pioneering data curation to solve complex diseases

[Qureight @qureight]

Today we announce the appointment of Dr. Simon Walsh as our new Chief Scientific Officer. Link and video below.

https://t.co/tsd48oAkCh

[BRAINOMIX @Brainomix]

Learn more about @DrPeter_George , Senior Medical Director at Brainomix, and a world-leading expert in Interstitial Lung Disease (ILD). ⬇
https://t.co/vXCQimYSzN

#ILD #pulmonology #biomarkers #IPF #lungdisease

[Qureight @qureight]

Our multi year strategic partnership with @AstraZeneca is an important relationship to us. We presented results on machine learning in lung disease imaging to predict patient outcomes at this year's American Thoracic Society meeting in San Diego.

[AstraZeneca @AstraZeneca]

We’re working with @qureight to leverage AI to quantify radiological features in idiopathic pulmonary fibrosis. Learn more about our work in AI: https://t.co/Ev9YfbQRJF #ATS2024

[AstraZeneca @AstraZeneca]

We’re working with @qureight to leverage AI to quantify radiological features in idiopathic pulmonary fibrosis. Learn more about our work in AI: https://t.co/Ev9YfbQRJF #ATS2024

[Mind @MindCharity]

It’s Mental Health Awareness Week 🎉

If you’re needing a little support, here’s who to call ☎️

[Qureight @qureight]

We will be attending the @atscommunity Conference (#ATS2024) this month in San Diego!

We're excited to catch up with fellow Respiratory research colleagues in the field!

Muhunthan T, Dan G & Simon W will be there, drop us an email to catch up over coffee☕️➡️[email protected]

[Qureight @qureight]

@jspujji Gateway X

[Qureight @qureight]

See our latest paper in AJRCCM here.

[Phil Molyneaux @drphilmol]

Predicting progressive disease and mortality in IPF using automated analysis of CT scans. A massive collaborative effort between @ImperialNHLI @qureight & @AstraZeneca now in press @ATSBlueEditor #cureipf

https://t.co/me3Ulza28m

[Milner Therapeutics Institute @TheMilnerInst]

We had a great time at the Milner x @CamGravity Biotech Matchmaking event last week, and were delighted to welcome many of our affiliated companies there!

Don't miss the @CambridgeIndy piece linked below to find out more! 👇

https://t.co/8UTrl7qGhg

[Qureight @qureight]

The Qureight annual dinner. Amazing to see how big our team has grown even in the space of just 12 months :)

[Qureight @qureight]

Great to be listed on the 21 to watch longlist this year

[cofinitive @cofinitive]

Congratulations to the latest additions to the #21toWatch longlists! Sam Nallaperuma (@sam123sam) Daniel de la Torre, Broderick House @AgriSynth @qureight @Cambrionix Vector Bioscience @WeAreWatr and UbisonOne System by Smart Acoustics https://t.co/rRl7t46PlU

[Qureight @qureight]

Celebrating a recent commercial success and welcoming our new software engineer Jack to the team this week. #workhardplayhard

[Qureight @qureight]

Reall excited to announce the appointment of Dr. Xose Fernandez to our Scientific Advisory Board. He brings a wealth of experience in data strategy and will be transformative to our plans for growth.

https://t.co/YLlbNJ9Qcx

[Qureight @qureight]

Today we announce that we have gained ISO13485 certification. A significant step forward in integrating our platform with clinical trials.

https://t.co/4P4La4wuKj

[Qureight @qureight]

A real honour to be named young company of the year by Business Weekly!

[Business Weekly @businessweekly]

The first award of the #BusinessWeeklyAwards event was for Young Company of the Year and was won by @qureight. Presented to CEO Muhunthan Thillai @mut75 by @claireruskin @cambnetwork. Congratulations! #MedTech https://t.co/VkUpt32aLA

[Qureight @qureight]

Announcing results from our first product (Lung8) at this year's @EuroRespSoc in Barcelona. Analysis of data from a @GalapagosGlobal phase 2 IPF study showed that we can do trials faster and cheaper in complex diseases.

[Qureight @qureight]

Fantastic to see our Scientific Board making waves in the biotech cluster

[Cambridge Biocapital @cBiocapital]

https://t.co/SYbhU6gnQY #023 |
@innovateuk budget boosted to £1 billion.

#SevenlessTherapeutics has secured €1.3 million funding. @Qureight has announced its Scientific BoD. Liz McKee Anderson has joined @GSK Board of Directors.

This and more below👇🏽
https://t.co/DCbcF04ofy

[Cambridge Biocapital @cBiocapital]

https://t.co/SYbhU6gnQY #023 |
@innovateuk budget boosted to £1 billion.

#SevenlessTherapeutics has secured €1.3 million funding. @Qureight has announced its Scientific BoD. Liz McKee Anderson has joined @GSK Board of Directors.

This and more below👇🏽
https://t.co/DCbcF04ofy

[Qureight @qureight]

Today we announce our IPF Scientific Advisory Board with leading global experts to help us implement our platform technology with a growing number of biopharma partners worldwide @TobyMMaher @drphilmol Paul Ford, Bill Bradford and Mel Wickremasinghe.

https://t.co/n3uT5h8ECg

[Qureight @qureight]

Qureight has ranked in Business Cloud's Top 50 for the UK's most innovative MedTech creators for 2022! A great start to week, we love to see others sharing in our vision!
https://t.co/9jo1bTbXjC